FIBROCELL SCIENCE
Fibrocell Science, Inc., is an autologous cell therapy company focused on the development of innovative products for aesthetic, medical and scientific applications. The fibroblast cell plays a key role in the production of collagen and growth factors which support the skin and other soft tissues; therefore, these cells could play a key role in treating many medical conditions. They have a robust pipeline and clinical programs based on the autologous fibroblast cell. They believe their aesthetic... indication is a beachhead for higher value indications. They have a strong base of knowledge and expertise in cell based product development, manufacturing and seeking regulatory approvals. Their focus is to enter clinical programs to treat medical conditions that have an unmet need, helping patients and creating more value per cell.
FIBROCELL SCIENCE
Industry:
Biotechnology Health Care Medical
Founded:
1995-01-01
Address:
Exton, Pennsylvania, United States
Country:
United States
Website Url:
http://www.fibrocellscience.com
Total Employee:
11+
Status:
Active
Contact:
(484)713-6000
Total Funding:
114.96 M USD
Technology used in webpage:
SPF SSL By Default Microsoft Exchange Online Office 365 Mail IPv6 ReCAPTCHA Microsoft Azure DNS Google Google Cloud ASP.NET
Similar Organizations
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
Current Employees Featured
Matthew Gantz President & Chief Executive Officer @ Fibrocell Science
President & Chief Executive Officer
Stock Details
Official Site Inspections
http://www.fibrocellscience.com
- Host name: 211.239.154.104.bc.googleusercontent.com
- IP address: 104.154.239.211
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
Fibrocellscience.com lookup results from whois.networksolutions.com server:
- Domain created: 16th-Jul-2009
- Domain updated: 17th-May-2024
- Domain expires: 16th-Jul-2025 0 Years, 89 Days left
- Website age: 15 Years, 276 Days
- Registrar Domain ID: 1562623158_DOMAIN_COM-VRSN
- Registrar Url: http://networksolutions.com
- Registrar WHOIS Server: whois.networksolutions.com
- Registrar Abuse Contact Email: domain.operations@web.com
- Registrar Abuse Contact Phone: +1.8777228662
- Name server:
- NS49.WORLDNIC.COM
- NS50.WORLDNIC.COM
More informations about "Fibrocell Science"
Fibrocell Science - Crunchbase Company Profile
Fibrocell Science, Inc., is an autologous cell therapy company focused on. the development of innovative products for aesthetic, medical and scientific …See details»
Fibrocell Science - LinkedIn
Fibrocell Science | 1,504 followers on LinkedIn. Focused on improving the lives of people with rare diseases of the skin and connective tissue | Fibrocell is a cell and gene therapy company ...See details»
Fibrocell Science Inc - Company Profile and News
Fibrocell Science Inc. is a cell and gene therapy company. The company focuses on diseases affecting the skin and connective tissue. Fibrocell Science Inc. uses proprietary autologous …See details»
Fibrocell Science Company Profile - Office Locations ... - Craft
Jun 30, 2021 Fibrocell Science is an autologous cell and gene therapy company, focusing on discovering and developing therapies for diseases affecting the skin, connective tissues and …See details»
Fibrocell Science acquired by Castle Creek Biosciences - Crunchbase
Fibrocell Science Fibrocell Science is an autologous cell therapy company developing products for aesthetic, medical and scientific applications. Acquiring Organization: Castle Creek …See details»
Isolagen, Inc. Reorganizes as Fibrocell Science, Inc.; Names New …
Oct 6, 2009 About Fibrocell Science, Inc. Fibrocell Science, Inc., (OTC Bulletin Board: FCSC) is a biotechnology company focused on developing regenerative fibroblast cells for aesthetic, …See details»
Fibrocell Science, Inc. Announces $45 Million Private Placement …
Oct 9, 2012 Fibrocell Science, Inc. (FCSC), a biotechnology company focused on commercializing LAVIV, the first and only FDA-approved personalized cell therapy in aesthetic …See details»
Fibrocell Science, Inc. Announces FDA Approval for laViv(R) (azficel …
Jun 22, 2011 Fibrocell Science, Inc. Announces FDA Approval for laViv(R) (azficel-T) EXTON, Pa., Jun 22, 2011 (BUSINESS WIRE) -- Fibrocell Science, Inc. , a cell therapy company …See details»
Fibrocell Science Inc. - Cruelty Free Investing
Fibrocell is a cell and gene therapy company, which focuses on diseases affecting the skin and connective tissue. By extracting fibroblast cells from a patient’s own skin, they create localized …See details»
Fibrocell Science, Inc. Announces FDA Approval for laVÃv(R
Jun 22, 2011 Fibrocell Science, Inc. (OTCBB:FCSC.OB) is a cell therapy company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and …See details»
Fibrocell Science Employee Reviews in Exton, PA - Indeed
Sep 5, 2024 Reviews from Fibrocell Science employees about Fibrocell Science culture, salaries, benefits, work-life balance, management, job security, and more. Working at Fibrocell …See details»
Fibrocell Science, Inc. Announces Scientific Collaboration with …
Mar 8, 2011 Fibrocell Science, Inc. David M. Pernock President & CEO 484-713-6000 davidpernock@fibrocellscience.com or ICR, LLC Sherry Bertner Managing Director 646-277 …See details»
Fibrocell Science, Inc. (FCSC) Stock Price, News ... - TheStreet
Apr 14, 2016 Find the latest Fibrocell Science, Inc., FCSC stock market data. Get a full understanding of how Fibrocell Science, Inc. is performing with stock quotes and prices, as …See details»
Fibrocell Science Appoints Robert Sheroff, Vice President of …
Jan 10, 2014 Fibrocell Science, Inc. (NYSE MKT:FCSC) is an autologous cell therapy company primarily focused on developing first-in-class treatments for skin diseases and conditions with …See details»
FDA Grants Orphan Drug Designation to Fibrocell's FCX-013, a …
Apr 28, 2016 FCX-013 is the company’s second gene-therapy candidate receiving orphan drug designation, the other being FCX-007. The FDA also recently approved the start of a Phase …See details»
Fibrocell Announces Collaboration with Castle Creek
April 15, 2019 06:30 ET | Source: Fibrocell Science Inc. - Fibrocell to receive up to $135 million, including up to $30 million in upfront, near-term and development payments and a 30% gross ...See details»
Fibrocell captures FDA approval for personalized wrinkle treatment
Jun 22, 2011 Fibrocell Science ($FCSC) has won FDA approval to market a new competitor to Botox which uses a sample of a person's cells to create an individualized therapy to ...See details»
Fibrocell Announces FDA Fast Track Designation of FCX-007
Jan 5, 2017 Contact Data Investor Relations Contact Annie Cheng 646-362-8804 acheng@clermontpartners.com Media Relations Contact Karen Casey 484-713-6133 …See details»
Fibrocell Science, Inc. Submits Complete Response to FDA …
Dec 20, 2010 Fibrocell Science, Inc. Submits Complete Response to FDA Regarding Azficel-T EXTON, Pa.--(BUSINESS WIRE)--Dec 20, 2010 - Fibrocell Science, Inc. (OTCBB: FCSC), a …See details»
Fibrocell Science, Inc. to Initiate Phase II Clinical Trial for ...
Dec 18, 2012 Fibrocell Science, Inc., a biotechnology company at the forefront of research into the potential medical and aesthetic use of fibroblasts, plans to initiate a Phase II clinical trial to …See details»